Top Smart Score Stocks
Analysts' Top Stocks
Insiders' Hot Stocks
Daily Stock Ratings
Daily Insider Transactions
Electronic Vehicles Stocks
Coronavirus Vaccine Stocks
High Dividend Stocks
My Portfolio Analysis
Profile & Performance
My Public Profile
Find & Follow Experts
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
Ideas & Insights
Calendars & Events
Stock Market Holidays
Become an Affiliate
Plans & Pricing
Sorrento Teams with Mayo Clinic and Gets UK Approval for Phase 2 Trial for COVI-DROPS; Shares Roar 5%
Shares of the biopharmaceutical company Sorrento Therapeutics (SRNE) jumped 5.1% in Friday’s extended trading session after the company...
Jun 14, 2021
Sorrento: Near-Term Developments Could Catapult Shares Higher
Anyone keeping track of the progress being made at Sorrento Therapeutics (SRNE), will be aware the company has...
Jun 07, 2021
Sorrento: The Monoclonal Antibody Portfolio Charges Ahead
The developments are coming in thick and fast at Sorrento Therapeutics (SRNE). Recent times have seen a flurry...
Apr 30, 2021
Sorrento’s Subsidiary Scilex Gets FDA Nod For ZTlido Label Expansion
Sorrento Therapeutics’ subsidiary, Scilex Holding, has received approval from the US Food and Drug Administration (FDA) for its...
Apr 12, 2021
Is Sorrento Stock a Buy Following ACEA Acquisition? Analyst Weighs In
Sorrento (SRNE) is not a company to rest on its laurels, particularly on the acquisition front. There have...
Apr 07, 2021
Sorrento Inks Deal To Buy ACEA Therapeutics; Shares Gain 3%
Shares of Sorrento Therapeutics increased 3.3% to close at $8.27 on April 5 after the clinical-stage antibody-centric biopharmaceutical...
Apr 06, 2021
Why Sorrento Is a $26 Stock
Once a specialist in oncology drugs and pain management, last year, Sorrento Therapeutics (SRNE) refocused its business on...
Mar 29, 2021
Sorrento Stock Is a Buy Because of Its Strong Drug Pipeline, Says Analyst
Sorrento (SRNE) has a multi-pronged approach to therapeutics. The company has been constantly adding new options to its...
Mar 04, 2021
Sorrento: New Platform Further Underscores the Bull Case
Not content with boasting a pipeline bursting at the seams with multiple candidates in various stages of development,...
Feb 09, 2021
Sorrento: Breaking Down B. Riley’s New Bullish Call
Diversifying a portfolio is often cited as a safe investing strategy, but it is also the game plan...
Feb 01, 2021
Sorrento Stock Has Multiple Catalysts in Play; Analyst Says ‘Buy’
Some companies favor a “do one job and do it well” approach. However, that is not the Sorrento...
Jan 25, 2021
Sorrento Stock Could Hit $30, Says Analyst
The major U.S. equity-indexes are hovering around all-time highs, and a question that frequently pops up these days,...
Jan 15, 2021
Sorrento Pops 8% Pre-Market On FDA Application For Covid-19 Test
Shares of Sorrento Therapeutics spiked 8% in Wednesday’s pre-market trading after the drugmaker filed for emergency use of...
Dec 23, 2020
Sorrento Adds Stem Cell Treatment To Covid-19 Pipeline; Shares Rise
Shares in Sorrento rose 2.7% in Monday’s extended market session after the company entered into an exclusive license...
Oct 13, 2020
If COVID-19 Antibody ‘Cocktails’ Become Popular, Sorrento Stock Could Double, Says Analyst
Once a specialist in oncology drugs and pain management, Sorrento Therapeutics (SRNE) has pivoted to attack COVID-19 head-on...
Oct 06, 2020
Is Sorrento Stock a Buy Right Now? This Is What You Need to Know
Sorrento Therapeutics (SRNE) has taken a unique approach to fighting the coronavirus. While most pharma companies taking the...
Sep 28, 2020
Sorrento Spikes 11% On Positive RTX Epidural Data In Cancer Patients
Shares in Sorrento Therapeutics (SRNE) spiked 10.51% in Tuesday’s trading after the company released positive Phase 1b Study results...
Sep 23, 2020
Sorrento Pops 28% On FDA Nod To Kick Off Covid-19 Antibody Trial
Shares in Sorrento are surging 28% in Thursday’s pre-market session after the biotech company said it received US...
Sep 17, 2020
Sorrento Stock Is Dashing Towards a Brighter Future, Says Analyst
The coronavirus has thrust many previously unknown pharma companies into the spotlight. You can certainly place Sorrento Therapeutics...
Aug 31, 2020
Sorrento Ties The Knot With SmartPharm, Boosting Its Covid-19 Offering
Sorrento Therapeutics (SRNE) and SmartPharm Therapeutics have now signed a merger agreement for Sorrento to acquire SmartPharm, a...
Aug 21, 2020
Sorrento Dives 14% In Extended Trading After CFO Ousted
Sorrento sank 14% in extended market trading after the biotech company announced the ousting of its chief financial...
Aug 19, 2020
2 Top Coronavirus Stocks with Massive Upside Potential
Anywhere you turn, COVID-19’s impact can be seen. The deadly virus’ romp around the world and the lockdowns...
Aug 09, 2020
Sorrento’s New COVID-19 Test Could Be a Game Changer, Says 5-Star Analyst
Sorrento Therapeutics (SRNE) enjoyed yet another stellar day. Sure, there have been plenty of good weeks so far...
Aug 03, 2020
Sorrento To Buy SmartPharm For Potential Covid-19 Treatment; Top Analyst Says Buy
Sorrento (SRNE) has signed of a letter of intent to buy SmartPharm, to develop a pipeline of gene-encoded...
Jul 26, 2020
Upcoming Phase 2 COVID-19 Trial Marks Key Milestone for Sorrento (SRNE); Analyst Says ‘Buy’
A journey of a thousand miles begins with a single step, and a big one in this case....
Jul 24, 2020
Can This Coronavirus Stock Soar 230%? 5-Star Analyst Thinks So
Diversification is a tried-and-true strategy when investing in stocks. Drug maker Sorrento Therapeutics (SRNE) is applying the same...
Jul 09, 2020
Sorrento Edges Higher On Debt Repayment As Top Analyst Says Buy
Shares in Sorrento Therapeutics (SRNE) edged 5% higher in Friday’s after-hours trading, after the company announced that it...
Jun 14, 2020
Sorrento Soars 17% In Pre-Market On Covid-19 Test Application
Shares in Sorrento (SRNE) are rallying 17% in Thursday’s pre-market trading after the company announced that an Application...
Jun 11, 2020
Top Analyst Sees More Than One Path to COVID-19 Solutions for Sorrento
Sorrento Therapeutics’ (SRNE) competitors might be further down the line with their COVID-19 programs, but H.C. Wainwright analyst...
Jun 10, 2020
Sorrento’s COVID-19 Cocktail Could Drive Major Upside, Says Analyst
Will a single antibody be enough to stomp out a COVID-19 infection? Sorrento Therapeutics (SRNE) says no. Rather,...
Jun 08, 2020
Sorrento Takes Another Leap Forward with Recent FDA Clearance, Says Top Analyst
And the W’s just keep on coming for Sorrento Therapeutics (SRNE). Reflecting a major step forward in the...
May 27, 2020
Sorrento’s COVID-19 Antidote Could be a Game Changer, Says Analyst
How do we protect those at the frontline facing COVID-19 head on? Sorrento Therapeutics (SRNE) is on it....
May 26, 2020
Sorrento (SRNE) Stock Is up 140% in Two Days. How Much Higher Can It Go?
Head back to Thursday’s market close and shares of drug maker Sorrento Therapeutics (SRNE) were trading for $2.62,...
May 18, 2020